Present for the Journey.

GOVERNMENT agencies; PHARMACEUTICAL industry; SOCIAL security; CHINA. Food & Drug Administration; CENTER for Drug Evaluation & Research (U.S.); CENTER for Biologics Evaluation & Research (U.S.)

The article focuses on creating government affairs (GA) organization in China and the growth of the pharmaceutical industry in the country. Topics discussed include the move of the Chinese government to expand the coverage of social insurance, the Chinese Food and Drug Administration (CFDA), and the role of the U.S. Center for Drug Evaluation (CDER) and the Center for Biologics and Research (CBER) in regulating pharmaceutical companies.